Excellent long term survival of front-line high-dose chemotherapy with rituximab (HDT) in

被引:0
|
作者
Dilhuydy, M. [1 ]
Lamy, T. [2 ]
Casassus, P. [3 ]
Deconninck, E. [4 ]
Gressin, R. [5 ]
Le Maignan, C. [6 ]
Milpied, N. [1 ]
机构
[1] CHU Bordeaux, F-93009 Pessac, France
[2] CHU Rennes, F-25030 Rennes, France
[3] Hop Avicenne, Bobigny, France
[4] CHU Besancon, Hematol & BMT Unit, Besancon, France
[5] Hop Michallon, Grenoble, France
[6] Hop Europeen Georges Pompidou, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:147 / 148
页数:2
相关论文
共 50 条
  • [31] High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study
    Roccatello, Dario
    Sciascia, Savino
    Rossi, Daniela
    Alpa, Mirella
    Naretto, Carla
    Radin, Massimo
    Barreca, Antonella
    Fenoglio, Roberta
    Baldovino, Simone
    Menegatti, Elisa
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (02) : 108 - 113
  • [32] Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan
    Ma, Wei -Li
    Liu, Wang-Da
    Sun, Hsin-Yun
    Sheng, Wang-Huei
    Hsieh, Szu-Min
    Wu, Shang-Ju
    Hung, Chien-Ching
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (03) : 426 - 436
  • [33] Prolonged survival in patients with diffuse large B-cell lymphoma and aaIPI Score 2-3 receiving front-line rituximab-supplemented high-dose chemotherapy with multiple autologous haematopoietic stem cell support: a prospective multicentre study
    Tarella, C.
    Zanni, M.
    Di Nicola, M.
    Patti, C.
    Calvi, R.
    Pescarollo, A.
    Zoli, V.
    Caracciolo, D.
    Ladetto, M.
    Magni, M.
    Devizzi, L.
    Rosato, R.
    Boccadoro, M.
    Bregni, M.
    Corradini, P.
    Gallamini, A.
    Majolino, I.
    Mirto, S.
    Gianni, A. M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S144 - S144
  • [34] Addition of Rituximab to High-Dose Methotrexate-Based Chemotherapy Improves Survival of Adults with Burkitt Lymphoma/Leukemia
    Dujmovic, Dino
    Aurer, Igor
    Radman, Ivo
    Serventi-Seiwerth, Ranka
    Dotlic, Snjezana
    Stern-Padovan, Ranka
    Dubravcic, Klara
    Santek, Fedor
    Labar, Boris
    ACTA HAEMATOLOGICA, 2012, 127 (02) : 115 - 117
  • [35] Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study
    A Gonçalves
    R Delva
    M Fabbro
    L Gladieff
    J-P Lotz
    J-M Ferrero
    C Linassier
    P-H Cottu
    P Viens
    J-M Extra
    Bone Marrow Transplantation, 2006, 37 : 651 - 659
  • [36] Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer:: a phase II multicentre study
    Gonçalves, A
    Delva, R
    Fabbro, M
    Gladieff, L
    Lotz, JP
    Ferrero, JM
    Linassier, C
    Cottu, PH
    Viens, P
    Extra, JM
    BONE MARROW TRANSPLANTATION, 2006, 37 (07) : 651 - 659
  • [37] Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
    Wei-Li Ma
    Hsin-An Hou
    Ya-Jui Hsu
    Yin-Kai Chen
    Jih-Luh Tang
    Woei Tsay
    Po-Ting Yeh
    Chung-May Yang
    Chang-Ping Lin
    Hwei-Fang Tien
    Annals of Hematology, 2016, 95 : 593 - 601
  • [38] Erratum: High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review
    T Reljic
    A Kumar
    B Djulbegovic
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2015, 50 : 1144 - 1144
  • [39] Intensive sequential chemotherapy (+/-rituximab) and front-line autotransplantation improves remission rate and survival in patients with poor prognosis non-Hodgkin's lymphomas
    Papajík, T
    Raida, L
    Faber, E
    Procházka, V
    Skoumalova, I
    Tichy, M
    Kucerova, L
    Jarosova, M
    Kajaba, V
    Zapletalova, J
    Indrak, K
    ANNALS OF ONCOLOGY, 2005, 16 : 183 - 183
  • [40] Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
    Ma, Wei-Li
    Hou, Hsin-An
    Hsu, Ya-Jui
    Chen, Yin-Kai
    Tang, Jih-Luh
    Tsay, Woei
    Yeh, Po-Ting
    Yang, Chung-May
    Lin, Chang-Ping
    Tien, Hwei-Fang
    ANNALS OF HEMATOLOGY, 2016, 95 (04) : 593 - 601